المؤلفون: M, Wolbers, H C, Bucher, H, Furrer, M, Rickenbach, M, Cavassini, R, Weber, P, Schmid, E, Bernasconi, B, Hirschel, M, Battegay, S, Yerly

المساهمون: University of Zurich, Battegay, M

المصدر: HIV medicine, Vol. 9, No 6 (2008) pp. 397-405

مصطلحات موضوعية: Adult, Male, medicine.medical_specialty, Human immunodeficiency virus (HIV), 610 Medicine & health, HIV Infections, medicine.disease_cause, Group A, Group B, Anti-Retroviral Agents/therapeutic use, Drug Administration Schedule, 10234 Clinic for Infectious Diseases, Risk Factors, Internal medicine, 2736 Pharmacology (medical), Medicine, Humans, Pharmacology (medical), Late initiation, ddc:616, CD4 Lymphocyte Count/standards, AIDS-Related Opportunistic Infections, business.industry, Health Policy, AIDS-Related Opportunistic Infections/prevention & control, 2725 Infectious Diseases, Viral Load, 2719 Health Policy, Antiretroviral therapy, CD4 Lymphocyte Count, HIV Infections/diagnosis/drug therapy, Institutional repository, Infectious Diseases, Early Diagnosis, Anti-Retroviral Agents, 10036 Medical Clinic, RNA, Viral/analysis, Cohort, Immunology, Disease Progression, HIV-1, RNA, Viral, Female, business, Cohort study

وصف الملف: 11239V.pdf - application/pdf

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::248459e8aab62f3af150141d4600d727
https://archive-ouverte.unige.ch/unige:2097